Sign Up to like & get
recommendations!
1
Published in 2017 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2017.35.15_suppl.9032
Abstract: 9032Background: The EGFR-T790M somatic mutation is the most common mechanism of resistance to Tyrosine Kinase Inhibitors (TKI) in NSCLC. However patients with advanced disease are not always amenab...
read more here.
Keywords:
t790m mutations;
egfr t790m;
mutations exhaled;
detection egfr ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2017 at "Oncotarget"
DOI: 10.18632/oncotarget.22530
Abstract: Background The detection of EGFR and KRAS mutations of metastatic lung adenocarcinoma using liquid-based cytology suspension routine specimens from fine-needle aspiration remains controversial. Results The DNA of all specimens was extracted and real time PCR…
read more here.
Keywords:
egfr kras;
metastatic lung;
detection egfr;
liquid based ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2019 at "Cancers"
DOI: 10.3390/cancers11060803
Abstract: Mutations in the epidermal growth factor receptor (EGFR) are associated with various solid tumors. This study aimed to compare two methods for the detection of EGFR mutations in circulating tumor DNA (ctDNA) from lung adenocarcinoma…
read more here.
Keywords:
mutations plasma;
detection egfr;
egfr mutations;
lung ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2018 at "Oncology letters"
DOI: 10.3892/ol.2017.7652
Abstract: Epithelial growth factor receptor (EGFR)-tyrosine kinase inhibitors are the standard first-line treatment for patients with metastatic non-small cell lung cancer (NSCLC) expressing sensitive EGFR-mutants. Other drugs target different driver mutants, including the serine/threonine-protein kinase B-raf…
read more here.
Keywords:
detection;
braf;
detection egfr;
allele specific ... See more keywords